Calcium Hydroxylapatite is frequently used as a semipermanent wrinkle filler on the epidermis. It is used to treat facial lines and restore facial volume loss. The atheist medication calcium hydroxylapatite is used to increase volume to soft facial tissues. Calcium hydroxylapatite is non-hazardous and has a high level of flexibility and viscosity, which contributes to the formation of collagen over time. Calcium hydroxylapatite possesses properties such as viscosity, flexibility, and adhesion. Calcium hydroxylapatite is administered intravenously through a micro-cannula with a short point. The market for calcium hydroxylapatite (CaHA) fillers is expected to grow quickly due to more people caring about how they look and getting cosmetic treatments, as well as more dermatological consultancies and clinics opening up. Patients are also more comfortable with dermal filler treatments because they hurt less. These things should help the calcium hydroxylapatite (CAHA) plugs market grow around the world.
Top Companies in the Calcium Hydroxylapatite (CaHA) Fillers Industry:
1. Allergan plc
Allergan plc is an American pharmaceutical company based in Ireland. It buys, develops, makes, and sells brand-name drugs and medical products in the fields of medical aesthetics, eye care, central nervous system, and gastroenterology. It was founded in 2013 and headquartered in Dublin, Ireland. It operates in approximately 100 countries. In October of 2020, Allergan, a global pharmaceutical company, acquired Luminera filler ranges from AbbVie and engaged into an agreement with Luminera, a privately held aesthetics company. Allergan will acquire its entire portfolio of dermal fillers, including HArmonyCa, dermal filler intended for facial soft tissue augmentation that consists of cross-linked hyaluronic acid (HA) with embedded calcium hydroxyapatite (CaHA) microspheres. The Luminera portfolio of dermal fillers also includes a line of HA dermal fillers as well as CaHA-based fillers marketed in multiple markets.
2. Galderma Laboratories
Galderma Laboratories is a Swiss pharmaceutical business that specializes in treatments and products for the skin. It was founded in 1981 and headquartered in Zug, Switzerland. It operates in over 100 countries. Galderma will expand its manufacturing and innovation footprint in Asia-Pacific in October 2022.
3. Merz Pharma GmbH & Co. KGaA
Merz Pharma GmbH & Co. KGaA is an internationally active family-owned company. It was founded in 1908 and headquartered in Frankfurt am Main, Germany. It operates in more than 20 countries. In Feb 2022, Merz Aesthetics, the world's largest medical aesthetics company, has started selling the Radiesse® (+) Lidocaine injectable implant for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation for treating moderate to severe loss of jawline contour in adults over the age of 21. Radiesse Injectables are the only calcium hydroxylapatite (CaHA) injectables in the United States, and Radiesse (+) is the only FDA-approved injectable treatment for enhancing jawline morphology.
4. Cynosure Inc
Cynosure Inc was founded in 1991 and headquartered in Massachusetts, United States. It operated in over 130 countries. In March of 2018, Zensar, an RPG company, and the management of Cynosure Inc. announced a definitive agreement to acquire the US-based Cynosure Inc.
5. Prollenium Medical Technologies, Inc
Prollenium Medical Technologies, Inc was founded in 2002 and headquartered in Ontario, Canada. It operates in more than 80 countries world-wide.
6. Dr. Korman Laboratories Ltd
Dr. Korman Laboratories Ltd was founded in 2009 and headquartered in Hefa, Israel. It operates in over 50 countries worldwide.
7. Luminera
Luminera is both a research and development corporation and a manufacturer of injectable medical devices in the field of aesthetic medicine. It was founded in 2013 and headquartered in HaMerkaz, Israel. It operates in over 57 countries worldwide.
8. CG Bio Co., Ltd
CG Bio Co., Ltd was founded in 2006 and headquartered in Seoul, South Korea. It operates in Nepal, India, Serbia, Kazakhstan, Bangladesh, and Egypt and also globally. In April 2023, CGBio went to the Global Beauty and Anti-Aging Academic Conference (AMWC) and signed a 16.5-billion-won deal to be a supplier of the calcium filler Facetem. Visitors were very interested in CGBio's cosmetic surgery total solution products, which were made using the company's regenerative medicine technology. These products include the hyaluronic acid (HA) filler Aileene, the calcium hydroxyapatite (CaHA) filler Facetem, the SVF full-auto extractor CELLUNIT, the breast massager BELUNA, the microneedle patch DERMAREGEN, and the lifting thread EXOFT.
9. Medyglobal
Medyglobal was founded in 2018 and headquartered in Madrid, Spain. It operates in multiple countries.
10. Teoxane SA.
Teoxane SA. was founded in 2003 and headquartered in Geneva, Switzerland. It operates in more than 95 countries worldwide. Biotechnology company Revance Therapeutics, Inc. signed a U.S. distribution agreement with Approved Dermal Fillers from TEOXANE SA in January 2020. This made Revance the exclusive commercialization partner for the Swiss company's modern and innovative Resilient Hyaluronic Acid® (RHA®) technology. The TEOXANE SA RHA® portfolio is the first and only collection of dermal fillers approved by the FDA for the correction of dynamic wrinkles.
Definition: Calcium hydroxylapatite (CaHA) is an injectable dermal filler composed of microspheres of CaHA dispersed in an aqueous carboxymethylcellulose gel carrier. It is considered a long-lasting, nonpermanent substance that is highly biocompatible with human tissue
